These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 35038779)

  • 21. Serotonin Release Assay: Functional Assay for Heparin- and Vaccine-Induced (Immune) Thrombotic Thrombocytopenia.
    Kondo M; Donikian D; Brighton TA
    Methods Mol Biol; 2023; 2663():463-477. PubMed ID: 37204730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet-Activating Antibodies Are Detectable at the Earliest Onset of Heparin-Induced Thrombocytopenia, With Implications for the Operating Characteristics of the Serotonin-Release Assay.
    Warkentin TE; Arnold DM; Kelton JG; Sheppard JI; Smith JW; Nazy I
    Chest; 2018 Jun; 153(6):1396-1404. PubMed ID: 29325985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beneficial effect of exogenous platelet factor 4 for detecting pathogenic heparin-induced thrombocytopenia antibodies.
    Vayne C; Guery EA; Kizlik-Masson C; Rollin J; Bauters A; Gruel Y; Pouplard C
    Br J Haematol; 2017 Dec; 179(5):811-819. PubMed ID: 29048130
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serotonin-release assay-positive but platelet factor 4-dependent enzyme-immunoassay negative: HIT or not HIT?
    Warkentin TE; Smythe MA; Ali MA; Aslam N; Sheppard JI; Smith JW; Moore JC; Arnold DM; Nazy I
    Am J Hematol; 2021 Mar; 96(3):320-329. PubMed ID: 33326124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Importance of the FcgammaRIIa-Arg/His-131 polymorphism in heparin-induced thrombocytopenia diagnosis.
    Bachelot-Loza C; Saffroy R; Lasne D; Chatellier G; Aiach M; Rendu F
    Thromb Haemost; 1998 Mar; 79(3):523-8. PubMed ID: 9531034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of heparin-induced thrombocytopenia.
    Warkentin TE; Greinacher A
    Curr Opin Hematol; 2016 Sep; 23(5):462-70. PubMed ID: 27380556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heparin-activated procoagulant platelet assay: a flow cytometry-based functional test for heparin-induced thrombocytopenia.
    Pelzl L; Uzun G; Marini I; Zlamal J; Trumpp PN; Karakuyu A; Bakchoul T; Althaus K
    J Thromb Haemost; 2024 Feb; 22(2):470-479. PubMed ID: 37838242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of platelet factor 4 amino acids that bind pathogenic antibodies in heparin-induced thrombocytopenia.
    Huynh A; Arnold DM; Kelton JG; Smith JW; Horsewood P; Clare R; Guarné A; Nazy I
    J Thromb Haemost; 2019 Feb; 17(2):389-399. PubMed ID: 30582672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of intravenous immunoglobulin G to treat spontaneous heparin-induced thrombocytopenia.
    Irani M; Siegal E; Jella A; Aster R; Padmanabhan A
    Transfusion; 2019 Mar; 59(3):931-934. PubMed ID: 30556588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fibronectin modulates formation of PF4/heparin complexes and is a potential factor for reducing risk of developing HIT.
    Krauel K; Preuße P; Warkentin TE; Trabhardt C; Brandt S; Jensch I; Mandelkow M; Hammer E; Hammerschmidt S; Greinacher A
    Blood; 2019 Feb; 133(9):978-989. PubMed ID: 30573633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 5B9, a monoclonal antiplatelet factor 4/heparin IgG with a human Fc fragment that mimics heparin-induced thrombocytopenia antibodies.
    Kizlik-Masson C; Vayne C; McKenzie SE; Poupon A; Zhou Y; Champier G; Pouplard C; Gruel Y; Rollin J
    J Thromb Haemost; 2017 Oct; 15(10):2065-2075. PubMed ID: 28771917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determination of heparin-induced thrombocytopenia: a rapid flow cytometric assay for direct demonstration of antibody-mediated platelet activation.
    Tomer A; Masalunga C; Abshire TC
    Am J Hematol; 1999 May; 61(1):53-61. PubMed ID: 10331512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polymorphism of the Fcγ Receptor II as a Possible Predisposing Factor for Heparin-Induced Thrombocytopenia.
    Slavik L; Svobodova G; Ulehlova J; Krcova V; Hlusi A; Prochazkova J; Hutyra M
    Clin Lab; 2015; 61(8):1027-32. PubMed ID: 26427148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet-activating immune complexes identified in critically ill COVID-19 patients suspected of heparin-induced thrombocytopenia.
    Nazy I; Jevtic SD; Moore JC; Huynh A; Smith JW; Kelton JG; Arnold DM
    J Thromb Haemost; 2021 May; 19(5):1342-1347. PubMed ID: 33639037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Platelet Factor 4-Dependent Platelet Activation Assay Facilitates Early Detection of Pathogenic Heparin-Induced Thrombocytopenia Antibodies.
    Jones CG; Pechauer SM; Curtis BR; Bougie DW; Irani MS; Dhakal B; Pierce B; Aster RH; Padmanabhan A
    Chest; 2017 Oct; 152(4):e77-e80. PubMed ID: 28991552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HITlights: a career perspective on heparin-induced thrombocytopenia.
    Warkentin TE
    Am J Hematol; 2012 May; 87 Suppl 1():S92-9. PubMed ID: 22367928
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multicentre evaluation of 5B9, a monoclonal anti-PF4/heparin IgG mimicking human HIT antibodies, as an internal quality control in HIT functional assays: Communication from the ISTH SSC Subcommittee on Platelet Immunology.
    Pouplard C; Rollin J; Vayne C; Charuel N; Ahmadi Z; Alberio L; Azjenberg N; Althaus K; Bakchoul T; Chong B; Curtis BR; Faille D; Gomez FJ; Gresele P; Morel-Kopp MC; Mullier F; Nazy I; Smith JW; Greinacher A; Gruel Y
    J Thromb Haemost; 2022 Jan; 20(1):252-259. PubMed ID: 34657390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of platelets by sera containing IgG1 heparin-dependent antibodies: an explanation for the predominance of the Fc gammaRIIa "low responder" (his131) gene in patients with heparin-induced thrombocytopenia.
    Denomme GA; Warkentin TE; Horsewood P; Sheppard JA; Warner MN; Kelton JG
    J Lab Clin Med; 1997 Sep; 130(3):278-84. PubMed ID: 9341987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors for heparin-induced thrombocytopenia: Focus on Fcγ receptors.
    Rollin J; Pouplard C; Gruel Y
    Thromb Haemost; 2016 Oct; 116(5):799-805. PubMed ID: 27358188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heparin-induced thrombocytopenia: new insights into the impact of the FcgammaRIIa-R-H131 polymorphism.
    Carlsson LE; Santoso S; Baurichter G; Kroll H; Papenberg S; Eichler P; Westerdaal NA; Kiefel V; van de Winkel JG; Greinacher A
    Blood; 1998 Sep; 92(5):1526-31. PubMed ID: 9716579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.